Literature DB >> 18420158

Management of neurogenic orthostatic hypotension: an update.

Phillip A Low1, Wolfgang Singer.   

Abstract

Orthostatic hypotension (OH) is common in elderly people and in patients with disorders such as diabetes and Parkinson's disease. Grading of the severity of OH and its effect on the patient's quality of life are important. The symptoms vary with orthostatic stress, and subtle symptoms such as tiredness and cognitive impairment should be recognised. Standard drug treatment for OH is effective but worsens supine hypertension, whereas pyridostigmine can improve OH slightly but significantly without worsening of supine hypertension. Because orthostatic stress varies from moment to moment and drug treatment is suboptimal, drug treatment of OH needs to be combined with non-pharmacological approaches, such as compression of venous capacitance beds, use of physical counter-manoeuvres, and intermittent water-bolus treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18420158      PMCID: PMC2628163          DOI: 10.1016/S1474-4422(08)70088-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  46 in total

1.  Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease.

Authors:  L M Allcock; K Ullyart; R A Kenny; D J Burn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

2.  The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial.

Authors:  R Freeman; L Landsberg; J Young
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

3.  L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.

Authors:  C J Mathias; J M Senard; S Braune; L Watson; A Aragishi; J E Keeling; M D Taylor
Journal:  Clin Auton Res       Date:  2001-08       Impact factor: 4.435

4.  Importance of the splanchnic vascular bed in human blood pressure regulation.

Authors:  L B Rowell; J M Detry; J R Blackmon; C Wyss
Journal:  J Appl Physiol       Date:  1972-02       Impact factor: 3.531

5.  The pressor response to water drinking in humans : a sympathetic reflex?

Authors:  J Jordan; J R Shannon; B K Black; Y Ali; M Farley; F Costa; A Diedrich; R M Robertson; I Biaggioni; D Robertson
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

6.  Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study.

Authors:  B H Wood; J A Bilclough; A Bowron; R W Walker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 7.  Treatment of orthostatic hypotension.

Authors:  Roy Freeman
Journal:  Semin Neurol       Date:  2003-12       Impact factor: 3.420

8.  Association between supine hypertension and orthostatic hypotension in autonomic failure.

Authors:  David S Goldstein; Sandra Pechnik; Courtney Holmes; Basil Eldadah; Yehonatan Sharabi
Journal:  Hypertension       Date:  2003-06-30       Impact factor: 10.190

9.  Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension.

Authors:  W Singer; T L Opfer-Gehrking; B R McPhee; M J Hilz; A E Bharucha; P A Low
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

10.  Norepinephrine precursor therapy in neurogenic orthostatic hypotension.

Authors:  Horacio Kaufmann; Daniela Saadia; Andrei Voustianiouk; David S Goldstein; Courtney Holmes; Melvin D Yahr; Rachel Nardin; Roy Freeman
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

View more
  62 in total

Review 1.  Multiple system atrophy: a clinical and neuropathological perspective.

Authors:  Kiren Ubhi; Phillip Low; Eliezer Masliah
Journal:  Trends Neurosci       Date:  2011-09-29       Impact factor: 13.837

Review 2.  Short review: Acetylcholinesterase-inhibitors in Alzheimer's disease have opposing effects on blood pressure and cerebral perfusion.

Authors:  J A H R Claassen; A H E A van Beek; M G M Olde Rikkert
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

3.  Early discontinuation of treatment in patients with orthostatic hypotension.

Authors:  C Shibao; C G Grijalva; L A Lipsitz; I Biaggioni; M R Griffin
Journal:  Auton Neurosci       Date:  2013-08-20       Impact factor: 3.145

4.  Orthostatic hypotension leading to recurrent syncope episodes in a hypertensive patient: Treatment with Tianma Gouteng Decoction.

Authors:  Yun-fei Wang; La Zhang
Journal:  Chin J Integr Med       Date:  2013-10-30       Impact factor: 1.978

Review 5.  Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.

Authors:  Jacquie Baker; Kurt Kimpinski
Journal:  CNS Drugs       Date:  2017-08       Impact factor: 5.749

Review 6.  [Nonmotor symptoms in Parkinson's disease].

Authors:  W H Jost
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

7.  Spinal cord involvement in Lewy body-related α-synucleinopathies.

Authors:  Raffaele Nardone; Yvonne Höller; Francesco Brigo; Viviana Versace; Luca Sebastianelli; Cristina Florea; Kerstin Schwenker; Stefan Golaszewski; Leopold Saltuari; Eugen Trinka
Journal:  J Spinal Cord Med       Date:  2019-01-08       Impact factor: 1.985

Review 8.  Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension.

Authors:  Ahmed Elgebaly; Bassant Abdelazeim; Omar Mattar; Mohamed Gadelkarim; Rehab Salah; Ahmed Negida
Journal:  Clin Auton Res       Date:  2016-03-07       Impact factor: 4.435

9.  The Orthostatic Discriminant and Severity Scale (ODSS): an assessment of orthostatic intolerance.

Authors:  Jacquie Baker; Justin R Paturel; David M Sletten; Phillip A Low; Kurt Kimpinski
Journal:  Clin Auton Res       Date:  2019-01-02       Impact factor: 4.435

10.  Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project).

Authors:  Artur Fedorowski; Lars Stavenow; Bo Hedblad; Göran Berglund; Peter M Nilsson; Olle Melander
Journal:  Eur Heart J       Date:  2009-08-20       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.